Astec LifeSciences Limited

Equities

ASTEC

INE563J01010

Agricultural Chemicals

Market Closed - NSE India S.E. 07:43:47 2024-04-19 am EDT 5-day change 1st Jan Change
1,242 INR -1.52% Intraday chart for Astec LifeSciences Limited -4.51% +13.43%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Astec LifeSciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Astec LifeSciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Astec Lifesciences Raises INR490 Million from Bond Issue MT
Astec LifeSciences Limited Declares Final Dividend for the Financial Year Ended March 31, 2023 CI
Astec LifeSciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
India Ratings Gives AA- Rating to Astec Lifesciences' Bonds; Outlook Stable MT
Astec Lifesciences Swings to Loss in Fiscal Q4 as Revenue Halves MT
Astec LifeSciences Appoints CFO MT
Astec LifeSciences Limited Announces Chief Financial Officer Changes CI
Astec LifeSciences Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023, Payable by August 1, 2023 CI
Astec LifeSciences Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Astec LifeSciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Astec Lifesciences Opens New Chemical Research and Development Hub MT
Astec LifeSciences Limited Launches New Advanced Research and Development Center in Rabale, Maharashtra CI
Astec LifeSciences Limited Resume of Production Activity CI
ICRA Affirms AA- Rating on Astec Lifesciences' Long-term Bank Financing; Outlook Stable MT
Astec Lifesciences Closes Unit in Maharashtra, India, for Product Modification MT
Astec LifeSciences Limited Announces Shutdown of Unit At Taluka Mahad, District Raigad for Approximately Three Weeks CI
Astec Lifesciences Gets Board Nod to Raise Up To INR500 Million Via Issue of Debentures MT
Astec Lifesciences Limited Proposes to Raise Funds Through Issuance of Non-Convertible Debentures CI
Astec LifeSciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Astec LifeSciences Board to Consider Issuing Bonds to Raise Funds MT
Astec LifeSciences Appoints CFO MT
Astec Lifesciences Limited Announces Appointment of Mr. Madhur Gundecha as the Chief Financial Officer CI
Astec LifeSciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Chart Astec LifeSciences Limited
More charts
Astec LifeSciences Limited is an India-based company that is primarily engaged in manufacturing a range of agrochemical active ingredients and pharmaceutical intermediates. The Company operates through the Agrochemicals segment. It manufactures a range of fungicides, insecticides, herbicides, and intermediates for its global customers. The Company’s products and intermediates includes triazole fungicides, heterocyclic herbicides, sulfonylurea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, silane derivatives, fluorinated aromatic, aliphatic and heterocyclic intermediates, fluorinated aromatic amines, fluorinated pyridine derivatives, fluorinated aromatic carboxylic acids, fluorinated benzyl alcohols, fluorinated ketones and benzophenones, fluorinated heterocyclic mercaptans, heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, thorium salts, pyrazalone’s and heterocyclic sulfonyl chlorides.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1,242 INR
Average target price
1,108 INR
Spread / Average Target
-10.85%
Consensus
  1. Stock Market
  2. Equities
  3. ASTEC Stock
  4. News Astec LifeSciences Limited
  5. Astec LifeSciences' Consolidated Profit Surges in Fiscal Q3